Follicular Lymphoma — Trials

Follicular Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

775 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 216
Recruiting: 107
Ph III recruiting: 10
Growth YoY: −8.6%
Industry share: 29%
Top sponsor: City of Hope Medical Center
Termination share: 39.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (149)

clinicaltrialsPublishedShowing 1–16 of 16 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05749549	Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers	unknown	Phase 1 / Phase 2	191	Shanghai Blueray Biopharma Co., Ltd.INDUSTRY	1	Aug 7, 2024	clinicaltrials
NCT04763083	First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies	unknown	Phase 1	90	NovalGen Ltd.INDUSTRY	1	Jul 7, 2023	clinicaltrials
NCT05003141